Cara Therapeutics Investor Relations Material

Cara Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing therapies for pruritus and pain management. The company’s research centers on targeting peripheral kappa opioid receptors to treat itch and pain without central nervous system side effects. Cara Therapeutics serves the healthcare sector through research-driven pharmaceutical innovations. The company is headquartered in Stamford, Connecticut, and its shares are listed on the NASDAQ.